Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis

AIM:To investigate the impact of postoperative antiviral treatment on tumor recurrence and survival of patients with chronic hepatitis B virus(HBV) or hepatitis C virus(HCV) infection-related primary hepatocellular carcinoma(HCC) after curative therapy.METHODS:We performed a meta-analysis of randomi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2010-06, Vol.16 (23), p.2931-2942
Hauptverfasser: Miao, Ruo-Yu, Zhao, Hai-Tao, Yang, Hua-Yu, Mao, Yi-Lei, Lu, Xin, Zhao, Yi, Liu, Chang-Ning, Zhong, Shou-Xian, Sang, Xin-Ting, Huang, Jie-Fu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2942
container_issue 23
container_start_page 2931
container_title World journal of gastroenterology : WJG
container_volume 16
creator Miao, Ruo-Yu
Zhao, Hai-Tao
Yang, Hua-Yu
Mao, Yi-Lei
Lu, Xin
Zhao, Yi
Liu, Chang-Ning
Zhong, Shou-Xian
Sang, Xin-Ting
Huang, Jie-Fu
description AIM:To investigate the impact of postoperative antiviral treatment on tumor recurrence and survival of patients with chronic hepatitis B virus(HBV) or hepatitis C virus(HCV) infection-related primary hepatocellular carcinoma(HCC) after curative therapy.METHODS:We performed a meta-analysis of randomized and non-randomized control trials from electronic search and manual search.The fixed effect model of Mantel-Haenszel method and the random effect model of Der Simonian and Laird method were used for homogeneo...
doi_str_mv 10.3748/wjg.v16.i23.2931
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2887591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>1001267145</cqvip_id><wanfj_id>wjg201023014</wanfj_id><sourcerecordid>wjg201023014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c519t-322caf4d881ed0f3147c33a4dd251ac7cf9d129aad7dcfe5fc10f0f92ed336a53</originalsourceid><addsrcrecordid>eNpVUU2P0zAUtBCILQt3TsgHJE7p-iNuEg5IuxVf0kpwgLP11h-tS2KntpNV_z2OuixwsN5h5o3nzSD0mpI1b-r26v6wW890s3aMr1nH6RO0Yox2FWtr8hStKCFN1XHWXKAXKR0IYZwL9hxdMCLEpq3pCh2_h5TDaCJkNxsM-jDN4DMuz80uQo_zvoDjCdsQ8d6MhZddwjdXW1zwKVXR9JCNPmNBmb6feohYQVTOhwHeX-PBZKjAQ39KLr1Ezyz0ybx6mJfo56ePP7Zfqttvn79ur28rJWiXK86YAlvrtqVGE8tp3SjOodaaCQqqUbbTlHUAutHKGmEVJZbYjhnN-QYEv0QfzrrjdDcYrYzP5Rw5RjdAPMkATv6PeLeXuzBL1raN6GgReHsWuAdvwe_kIUyxHJFkiZ0RWtIktC60dw__xHCcTMpycGmJAbwJU5INX0IXLSlMcmaqGFKKxj6aoUQufS7CsvQpS59y6bOsvPn3iMeFPwX-Nan2we-Orti8A_XLut4UVULZpqG14L8BgfOsxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733352580</pqid></control><display><type>article</type><title>Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Miao, Ruo-Yu ; Zhao, Hai-Tao ; Yang, Hua-Yu ; Mao, Yi-Lei ; Lu, Xin ; Zhao, Yi ; Liu, Chang-Ning ; Zhong, Shou-Xian ; Sang, Xin-Ting ; Huang, Jie-Fu</creator><creatorcontrib>Miao, Ruo-Yu ; Zhao, Hai-Tao ; Yang, Hua-Yu ; Mao, Yi-Lei ; Lu, Xin ; Zhao, Yi ; Liu, Chang-Ning ; Zhong, Shou-Xian ; Sang, Xin-Ting ; Huang, Jie-Fu</creatorcontrib><description>AIM:To investigate the impact of postoperative antiviral treatment on tumor recurrence and survival of patients with chronic hepatitis B virus(HBV) or hepatitis C virus(HCV) infection-related primary hepatocellular carcinoma(HCC) after curative therapy.METHODS:We performed a meta-analysis of randomized and non-randomized control trials from electronic search and manual search.The fixed effect model of Mantel-Haenszel method and the random effect model of Der Simonian and Laird method were used for homogeneo...</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v16.i23.2931</identifier><identifier>PMID: 20556841</identifier><language>eng</language><publisher>United States: Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China%Bioinformatics Research Group, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100190, China</publisher><subject>Antiviral Agents - therapeutic use ; Brief ; Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - etiology ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - surgery ; Chemotherapy, Adjuvant ; Controlled Clinical Trials as Topic ; Hepatitis B, Chronic - complications ; Hepatitis B, Chronic - drug therapy ; Hepatitis C, Chronic - complications ; Hepatitis C, Chronic - drug therapy ; Humans ; Interferons - therapeutic use ; Liver Neoplasms - drug therapy ; Liver Neoplasms - etiology ; Liver Neoplasms - mortality ; Liver Neoplasms - surgery ; Neoplasm Recurrence, Local - prevention &amp; control ; Randomized Controlled Trials as Topic ; Survival Analysis</subject><ispartof>World journal of gastroenterology : WJG, 2010-06, Vol.16 (23), p.2931-2942</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2010 Baishideng. All rights reserved. 2010</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c519t-322caf4d881ed0f3147c33a4dd251ac7cf9d129aad7dcfe5fc10f0f92ed336a53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887591/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887591/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20556841$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miao, Ruo-Yu</creatorcontrib><creatorcontrib>Zhao, Hai-Tao</creatorcontrib><creatorcontrib>Yang, Hua-Yu</creatorcontrib><creatorcontrib>Mao, Yi-Lei</creatorcontrib><creatorcontrib>Lu, Xin</creatorcontrib><creatorcontrib>Zhao, Yi</creatorcontrib><creatorcontrib>Liu, Chang-Ning</creatorcontrib><creatorcontrib>Zhong, Shou-Xian</creatorcontrib><creatorcontrib>Sang, Xin-Ting</creatorcontrib><creatorcontrib>Huang, Jie-Fu</creatorcontrib><title>Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM:To investigate the impact of postoperative antiviral treatment on tumor recurrence and survival of patients with chronic hepatitis B virus(HBV) or hepatitis C virus(HCV) infection-related primary hepatocellular carcinoma(HCC) after curative therapy.METHODS:We performed a meta-analysis of randomized and non-randomized control trials from electronic search and manual search.The fixed effect model of Mantel-Haenszel method and the random effect model of Der Simonian and Laird method were used for homogeneo...</description><subject>Antiviral Agents - therapeutic use</subject><subject>Brief</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - etiology</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Controlled Clinical Trials as Topic</subject><subject>Hepatitis B, Chronic - complications</subject><subject>Hepatitis B, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - complications</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Humans</subject><subject>Interferons - therapeutic use</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - etiology</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - surgery</subject><subject>Neoplasm Recurrence, Local - prevention &amp; control</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Survival Analysis</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU2P0zAUtBCILQt3TsgHJE7p-iNuEg5IuxVf0kpwgLP11h-tS2KntpNV_z2OuixwsN5h5o3nzSD0mpI1b-r26v6wW890s3aMr1nH6RO0Yox2FWtr8hStKCFN1XHWXKAXKR0IYZwL9hxdMCLEpq3pCh2_h5TDaCJkNxsM-jDN4DMuz80uQo_zvoDjCdsQ8d6MhZddwjdXW1zwKVXR9JCNPmNBmb6feohYQVTOhwHeX-PBZKjAQ39KLr1Ezyz0ybx6mJfo56ePP7Zfqttvn79ur28rJWiXK86YAlvrtqVGE8tp3SjOodaaCQqqUbbTlHUAutHKGmEVJZbYjhnN-QYEv0QfzrrjdDcYrYzP5Rw5RjdAPMkATv6PeLeXuzBL1raN6GgReHsWuAdvwe_kIUyxHJFkiZ0RWtIktC60dw__xHCcTMpycGmJAbwJU5INX0IXLSlMcmaqGFKKxj6aoUQufS7CsvQpS59y6bOsvPn3iMeFPwX-Nan2we-Orti8A_XLut4UVULZpqG14L8BgfOsxw</recordid><startdate>20100621</startdate><enddate>20100621</enddate><creator>Miao, Ruo-Yu</creator><creator>Zhao, Hai-Tao</creator><creator>Yang, Hua-Yu</creator><creator>Mao, Yi-Lei</creator><creator>Lu, Xin</creator><creator>Zhao, Yi</creator><creator>Liu, Chang-Ning</creator><creator>Zhong, Shou-Xian</creator><creator>Sang, Xin-Ting</creator><creator>Huang, Jie-Fu</creator><general>Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China%Bioinformatics Research Group, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100190, China</general><general>Baishideng</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20100621</creationdate><title>Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis</title><author>Miao, Ruo-Yu ; Zhao, Hai-Tao ; Yang, Hua-Yu ; Mao, Yi-Lei ; Lu, Xin ; Zhao, Yi ; Liu, Chang-Ning ; Zhong, Shou-Xian ; Sang, Xin-Ting ; Huang, Jie-Fu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c519t-322caf4d881ed0f3147c33a4dd251ac7cf9d129aad7dcfe5fc10f0f92ed336a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>Brief</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - etiology</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Controlled Clinical Trials as Topic</topic><topic>Hepatitis B, Chronic - complications</topic><topic>Hepatitis B, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - complications</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Humans</topic><topic>Interferons - therapeutic use</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - etiology</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - surgery</topic><topic>Neoplasm Recurrence, Local - prevention &amp; control</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Survival Analysis</topic><toplevel>online_resources</toplevel><creatorcontrib>Miao, Ruo-Yu</creatorcontrib><creatorcontrib>Zhao, Hai-Tao</creatorcontrib><creatorcontrib>Yang, Hua-Yu</creatorcontrib><creatorcontrib>Mao, Yi-Lei</creatorcontrib><creatorcontrib>Lu, Xin</creatorcontrib><creatorcontrib>Zhao, Yi</creatorcontrib><creatorcontrib>Liu, Chang-Ning</creatorcontrib><creatorcontrib>Zhong, Shou-Xian</creatorcontrib><creatorcontrib>Sang, Xin-Ting</creatorcontrib><creatorcontrib>Huang, Jie-Fu</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miao, Ruo-Yu</au><au>Zhao, Hai-Tao</au><au>Yang, Hua-Yu</au><au>Mao, Yi-Lei</au><au>Lu, Xin</au><au>Zhao, Yi</au><au>Liu, Chang-Ning</au><au>Zhong, Shou-Xian</au><au>Sang, Xin-Ting</au><au>Huang, Jie-Fu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2010-06-21</date><risdate>2010</risdate><volume>16</volume><issue>23</issue><spage>2931</spage><epage>2942</epage><pages>2931-2942</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM:To investigate the impact of postoperative antiviral treatment on tumor recurrence and survival of patients with chronic hepatitis B virus(HBV) or hepatitis C virus(HCV) infection-related primary hepatocellular carcinoma(HCC) after curative therapy.METHODS:We performed a meta-analysis of randomized and non-randomized control trials from electronic search and manual search.The fixed effect model of Mantel-Haenszel method and the random effect model of Der Simonian and Laird method were used for homogeneo...</abstract><cop>United States</cop><pub>Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China%Bioinformatics Research Group, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100190, China</pub><pmid>20556841</pmid><doi>10.3748/wjg.v16.i23.2931</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2010-06, Vol.16 (23), p.2931-2942
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2887591
source MEDLINE; Baishideng "World Journal of" online journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Antiviral Agents - therapeutic use
Brief
Carcinoma, Hepatocellular - drug therapy
Carcinoma, Hepatocellular - etiology
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - surgery
Chemotherapy, Adjuvant
Controlled Clinical Trials as Topic
Hepatitis B, Chronic - complications
Hepatitis B, Chronic - drug therapy
Hepatitis C, Chronic - complications
Hepatitis C, Chronic - drug therapy
Humans
Interferons - therapeutic use
Liver Neoplasms - drug therapy
Liver Neoplasms - etiology
Liver Neoplasms - mortality
Liver Neoplasms - surgery
Neoplasm Recurrence, Local - prevention & control
Randomized Controlled Trials as Topic
Survival Analysis
title Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A42%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postoperative%20adjuvant%20antiviral%20therapy%20for%20hepatitis%20B/C%20virus-related%20hepatocellular%20carcinoma:A%20meta-analysis&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Miao,%20Ruo-Yu&rft.date=2010-06-21&rft.volume=16&rft.issue=23&rft.spage=2931&rft.epage=2942&rft.pages=2931-2942&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v16.i23.2931&rft_dat=%3Cwanfang_jour_pubme%3Ewjg201023014%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733352580&rft_id=info:pmid/20556841&rft_cqvip_id=1001267145&rft_wanfj_id=wjg201023014&rfr_iscdi=true